Sort
48,018 grants matching “immunotherapy”
Antigenic determinants of asthma-associated allergens for design of immunotherapy.
$776,237Anna Pomes · Indoor Biotechnologies · R01 · FY2017 · AI
Mechanisms of Clinical Reactivity or Tolerance to Mouse Allergen
$776,165Wayne G Shreffler · Massachusetts General Hospital · R01 · FY2011 · AI
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
$776,131Otto O Yang · University Of California Los Angeles · R01 · FY2024 · AI
Integrated Genomic and Functional Studies of Immunotherapy for Multi-Food Allergy
$776,000Stephen J Galli · Stanford University · U19 · FY2025 · AI
Development of Drugs Acting at Adenosine Receptors
$775,838Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Developing novel targeted therapeutics integrated with immunotherapy-based approaches to make breakthroughs in metastatic breast cancer
$775,816Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2016 · CA
Role of Th17 in Severe and Recurrent C. difficile Infection
$775,719William A Petri · University Of Virginia · R01 · FY2024 · AI
AUTOIMMUNE T AND B CELL RESPONSES IN TYPE 1 DIABETES
$775,688Stanford University · P01 · FY2000 · DK
AUTOIMMUNITY--MECHANISMS OF UNRESPONSIVENESS
$775,464Stanford University · P01 · FY2000 · AI
Antigenic determinants of asthma-associated allergens for design of immunotherapy
$775,425Anna Pomes · Indoor Biotechnologies · R01 · FY2025 · AI
Induction of autophagy to enhance CAR-T cells in HIV cure approaches
$775,321Anjie Zhen · University Of California Los Angeles · R01 · FY2023 · AI
Spontaneous and Induced B cell and T cell responses in Alzheimer's Disease
$775,250Marco Colonna · Washington University · R01 · FY2024 · AG
BCMA Specific Chimeric Antigen Receptor (CAR)-T Cells for Treatment of Patients with Multiple Myeloma
$775,192Damian J. Green · Fred Hutchinson Cancer Research Center · P01 · FY2019 · CA
Harnessing adaptive NK cell transfer to deplete viral reservoirs
$775,114David T Evans · University Of Wisconsin-Madison · R01 · FY2023 · AI
MANIPULATING MYELOID CELLS TO PROMOTE IMMUNOTHERAPY EFFICACY OF PANCREATIC DUCTAL ADENOCARCINOMA
$775,000Regents Of The University Of Minnesota · · FY2021 · Defense Health Agency
COOPERATIVE HUMORAL &CELLULAR IMMUNITY AGAINST HIV/SIV
$774,821Scripps Research Institute · R01 · FY2003 · AI
Clinical Translation of a Novel Diagnostic Agent to Predict Immunotherapy Response in Solid Tumors
$774,682James F Kronauge · Cytosite Biopharma, Inc. · R44 · FY2020 · CA
Clinical production of viral vectors for cancer gene therapy
$774,679Steven Feldman · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
Developing new immunotherapies based of CD4+ T cells
$774,677Nicholas Restifo · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Immunotherapeutics Against Arenaviruses
$774,498Robert F Garry · Scripps Research Institute, The · U19 · FY2015 · AI
Immunotherapy of inflammation, autoimmune disease and cancer
$774,498Wanjun Chen · National Institute Of Dental & Craniofacial Research · ZIA · FY2022 · DE
Myocardial Vulnerability to Ischemia-Induced Dysfunction and Heart Failure: The Impact of HIV/SIV, ART, and Targeted Immunotherapy
$774,257Matthew Joel Feinstein · Northwestern University At Chicago · R01 · FY2021 · HL
Engineering T cells to Promote Islet Transplant
$774,236James L Riley · University Of Pennsylvania · R01 · FY2024 · DK
Cytokines in AIDS and Cancer
$774,189George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells
$774,122Joji Fujisaki · Beth Israel Deaconess Medical Center · R01 · FY2025 · HL